Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Phase 3 trial results released by Protagonist Therapeutics has revealed that icotrokinra, an oral IL-23 receptor inhibitor, achieved clear or nearly clear skin in 66% of patients with ...

What is alopecia areata, and how does it differ from normal alopecia? Alopecia areata is an autoimmune condition that leads ...

Debbie Williams from Northampton, a 58-year-old director of a menswear business, has been living with psoriasis since she was just 7 years old. The discovery of a patch of psoriasis on her scalp as a ...

This guide covers key tools and communication features to make the most of technology in managing your health.